INSIDER TRADING

Kura Oncology, Inc. CEO Troy Edward Wilson buys $1.5M of stock, raising stake 42%

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Kura Oncology, Inc. CEO Troy Edward Wilson buys $1.5M of stock, raising stake 42%

The purchase raises the insider's holding by 42%, the filing shows. Information only, not investment advice.

Insider buying at Kura Oncology, Inc.: Troy Edward Wilson, the company's chief executive officer, bought 200,000 shares between Nov 13 and Nov 16 for $1.5 million, at an average of $7.52 a share, a Form 4 filed on Nov 16 shows.

The filing reports the shares as held indirectly, for example through a trust or a fund. With this purchase the insider holds 679,194 shares, 42% more than before.

The trade was reported within two business days, as Section 16 requires. It is the second insider purchase at Kura Oncology, Inc. reported in the last 90 days.

Details from the SEC filing:

The purchase
CompanyKura Oncology, Inc. (KURA)
InsiderTroy Edward Wilson
RoleCEO
TransactionOpen-market purchase (code P)
Shares200,000
Average price$7.52
Value$1,504,765
Trade datesNov 13 to Nov 16, 2026
Filed with the SECNov 16, 2026, 7:45 PM ET
Shares held after679,194
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

View the Form 4 on SEC.gov

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.